Indications
Ondansetron is indicated for:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy
Prevention of nausea and vomiting associated with radiotherapy
Prevention of post operative nausea and vomiting
Therapeutic Class
Anti-emetic drugs
Pharmacology
Ondansetron is a selective 5-HT3 receptor antagonist. While its mechanism of action has not been fully characterized, ondansetron is
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.